<DOC>
	<DOC>NCT00466180</DOC>
	<brief_summary>Taking antiretrovirals once-a-day is considered the simpler way to improve adherence. However, it is not know if this assertion apply to patients taking their medication twice-a-day who change to once-a-day. We hypothesized that once-daily dosing improves adherence.</brief_summary>
	<brief_title>Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>HIV1 infected adults receiving antiretroviral therapy including nevirapine twiceaday for at least 6 months plasma HIV RNA&lt;400 cp/ml during the previous 4 months on 2 occasions accept adherence electronic monitoring written informed consent signed asparate aminotransferase (AST) or alanine aminotransferase (ALT) &gt;2.5N if hepatitis virus B or C were negative AST or ALT&gt;1.25N if hepatitis virus B or C were positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Once-a-day</keyword>
	<keyword>Adherence</keyword>
	<keyword>Nevirapine</keyword>
	<keyword>Patient noncompliance</keyword>
	<keyword>Administration and dosage</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>